Editorial comment on "Maintenance bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials"

被引：0
|
作者：
Huang, Shu-Pin [1 ,2 ]
机构：
[1] Kaohsiung Med Univ Hosp, Dept Urol, 100 Tz You 1st Rd, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan
来源：
UROLOGICAL SCIENCE | 2015年 / 26卷 / 02期
关键词：
D O I：
10.1016/j.urols.2015.04.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / +
页数：2
相关论文
共 50 条
  • [1] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages EDITORIAL COMMENT
    Bandari, Jathin
    Maganty, Avinash
    Davies, Benjamin J.
    UROLOGY, 2019, 124 : 125 - 126
  • [2] Maintenance bacillus Calmette-Guerin in high-risk nonmuscle-invasive bladder cancer - How much is enough?
    Decobert, Marc
    LaRue, Helene
    Harel, Francois
    Meyer, Francois
    Fradet, Yves
    Lacombe, Louis
    CANCER, 2008, 113 (04) : 710 - 716
  • [3] Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer
    Camargo, Juliana A.
    Passos, Gabriela R.
    Ferrari, Karen L.
    Billis, Athanase
    Saad, Mario J. A.
    Reis, Leonardo O.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E587 - E593
  • [4] Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 204 (03): : 449 - 449
  • [5] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    UROLOGY, 2019, 124 : 120 - 125
  • [6] Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with nonmuscle-invasive bladder cancer: A meta-analysis
    Kazem Aghamir, Seyed Mohammad
    Khatami, Fatemeh
    Farrokhpour, Hossein
    Reis, Leonardo Oliveira
    Pishkuhi, Mahin Ahmadi
    Mohammad, Abdolreza
    PLOS ONE, 2022, 17 (05):
  • [7] Monthly maintenance protocol Bacillus Calmette-Guerin as a viable alternative to Southwest Oncology Group maintenance protocol in nonmuscle-invasive bladder cancer: A prospective randomized study
    Gupta, Naveen Kumar
    Sarkar, Debansu
    Pal, Dilip
    UROLOGY ANNALS, 2020, 12 (02) : 116 - 121
  • [8] A molecular signature determines the prognostic and therapeutic subtype of nonmuscle-invasive bladder cancer responsive to intravesical Bacillus Calmette-Guerin therapy
    Yun, S. J.
    Kang, H. W.
    Kim, W. T.
    Kim, Y-T.
    Lee, S-C.
    Kim, W-J.
    EUROPEAN UROLOGY, 2021, 79 : S614 - S614
  • [9] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
    Hugar, Lee A.
    Gilbert, Scott M.
    Sexton, Wade J.
    Kamat, Ashish M.
    Li, Roger
    CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
  • [10] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design EDITORIAL COMMENTS
    Matulewicz, Richard S.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1619 - 1620
12345